Home
>
US Stocks
>
Neoleukin Therapeutics Inc
Neoleukin Therapeutics Inc
NLTX

Neoleukin Therapeutics Inc (NLTX)

$6.888.69%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.88
Today Low/High
6.64 / 6.88
52 Week Low/High
$6.55 / $17.95
Market Cap
$287.22M

Company Details

Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Neoleukin's lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface.
Organisation
Neoleukin Therapeutics Inc
Employees
70
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Neoleukin Therapeutics Inc (NLTX) share price today?

Can Indians buy Neoleukin Therapeutics Inc (NLTX) shares?

How can I buy Neoleukin Therapeutics Inc (NLTX) shares from India?

Can Fractional shares of Neoleukin Therapeutics Inc (NLTX) be purchased?

What are the documents required to start investing in Neoleukin Therapeutics Inc (NLTX) stocks?

We are a SEBI registered investement advisor